Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United KingdomIPO:
01 October 2021Website:
http://www.exscientia.aiNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 7 min agoDividend
Analysts recommendations
Institutional Ownership
EXAI Latest News
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / If you suffered a loss on your Exscientia plc (NASDAQ:EXAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/exscientia-plc-lawsuit-submission-form?prid=87422&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / If you suffered a loss on your Exscientia plc (NASDAQ:EXAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/exscientia-plc-lawsuit-submission-form?prid=87392&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK , June 25, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Exscientia plc (NASDAQ: EXAI). Shareholders who purchased shares of EXAI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / If you suffered a loss on your Exscientia plc (NASDAQ:EXAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/exscientia-plc-lawsuit-submission-form?prid=87341&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / If you suffered a loss on your Exscientia plc (NASDAQ:EXAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/exscientia-plc-lawsuit-submission-form?prid=87332&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Exscientia p.l.c. ("Exscientia" or "the Company") (NASDAQ:EXAI) and certain of its officers.
NEW YORK, NY / ACCESSWIRE / June 25, 2024 / If you suffered a loss on your Exscientia plc (NASDAQ:EXAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/exscientia-plc-lawsuit-submission-form?prid=87327&wire=1 or contact Joseph E. Levi, Esq.
LOS ANGELES , June 25, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exscientia plc ("Exscientia" or "the Company") (NASDAQ: EXAI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between September 13, 2022 and October 9, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before June 25, 2024.
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming June 25, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Exscientia p.l.c. (“Exscientia” or the “Company”) (NASDAQ: EXAI) securities between March 23, 2022 and February 12, 2024, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On February 13, 2024, Exscientia announced that its CEO an.
NEW YORK, NY / ACCESSWIRE / June 24, 2024 / If you suffered a loss on your Exscientia plc (NASDAQ:EXAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/exscientia-plc-lawsuit-submission-form?prid=87256&wire=1 or contact Joseph E. Levi, Esq.
What type of business is Exscientia?
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
What sector is Exscientia in?
Exscientia is in the Healthcare sector
What industry is Exscientia in?
Exscientia is in the Biotechnology industry
What country is Exscientia from?
Exscientia is headquartered in United Kingdom
When did Exscientia go public?
Exscientia initial public offering (IPO) was on 01 October 2021
What is Exscientia website?
https://www.exscientia.ai
Is Exscientia in the S&P 500?
No, Exscientia is not included in the S&P 500 index
Is Exscientia in the NASDAQ 100?
No, Exscientia is not included in the NASDAQ 100 index
Is Exscientia in the Dow Jones?
No, Exscientia is not included in the Dow Jones index
When does Exscientia report earnings?
The next expected earnings date for Exscientia is 09 August 2024